Archives by
Month/Year
Under the microscope: are plans overpaying for newer therapies for Diabetes?
July 2011
The therapeutic mix of diabetic medications has changed drastically in the last five years, resulting in the wider use of newer and more expensive brand insulins, such as Lantus® and Levemir®, and oral products like Avandia® and Januvia®. The bottom line is View post
Biosimilar Chorionic Gonadotropin in Quebec – Clarification
July 2011
This article originally published in the July/August 2011 edition of Cubic Health Monthly contained inaccuracies that we would like to correct. We apologize very sincerely to our readers and to the stakeholders impacted by the incorrect information. In the article, we originally View post
NOC Watch – Jevtana, Zolmitriptan, Benlysta
July 2011
Jevtana® (cabazitaxel injection) Jevtana® is a new chemotherapy drug recently approved for the treatment of advanced prostate cancer that has become unresponsive to previous hormone therapy. This drug marks an important achievement for an area in need of clinical advances: prior to View post
Money down the drain – nobody benefits from non-adherence
July 2011
While drugs have the power to cure disease, manage symptoms and improve quality of life, according to the World Health Organization, only 50% of people taking long-term therapies for chronic conditions actually take their medication as prescribed.[1] Whatever the reason may be, View post
Panel discussion and Q&A: Practical applications for the workplace
July 2011
The new face of preferred pharmacy networks: what you need to know...
Latest News
-
N.S. tightens rules on OxyContin -Globe and Mail (February 20, 2012) - Provinces become proactive after being accused of inaction in the face of rising addiction rates - Nova Scotia has become the latest... View post
-
Another Blockbuster Falls: Generic Plavix® Now Available - February 2012 - After over 8 years of patent challenges between the Canadian generic manufacturing company Apotex and the product’s innovator, sanofi-aventis, clopidogrel (generic for... View post
-
Protecting Your Plan from the Gravy Train - February 2012 - Although full-product direct-to-consumer advertising (DTCA) is illegal in Canada, most Canadians are exposed to this type of advertising through media spillage from... View post
-
Many Canadians can’t afford to take drugs as directed -Globe and Mail (January 17, 2012) - One in four Canadians who do not have drug insurance are unable to afford to take their prescription drugs as directed, a... View post
-
Look ahead with predictive modelling -Benefits Canada (January 2012) - The most recent 24 months of data is one of the most important pieces of information that plan sponsors and advisors have... Download PDF
-
Drug Plans Erode Over Last 20 Years -Benefits and Pensions monitor (December 2011) - All of us involved in the provision and management of drug plan benefits should be embarassed by the lack of progress over... Download PDF
-
Are we in 2002 or 2012? A word of caution about mail-order pharmacies -Benefits Canada (November 2011) - If a plan design does not support mail order (or any other preferred pharmacy arrangement) in a meaningful way, it will be... Download PDF
Connect
